Dario Vignali is the founder of Novasenta. Novasenta has raised $60M in total funding. Latest round: Series A. Backed by UPMC Enterprises.
Dario Vignali is a co-founder of Novasenta, a biotechnology startup established in 2018. The company focuses on developing cancer therapies by identifying and validating new therapeutic targets. He co-founded Novasenta with Robert Ferris and Greg Delgoffe, utilizing research from UPMC Hillman Cancer Center and the University of Pittsburgh.
Full founder directory · Investor directory · Company funding database · Fundraising library